Alnylam Pharmaceuticals, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | — | -900.3% | -869.6% |
| FY2017 | 100.0% | -556.2% | -545.9% |
| FY2018 | 97.6% | -1,087.6% | -1,016.6% |
| FY2019 | 88.6% | -427.5% | -403.2% |
| FY2020 | 84.9% | -168.1% | -174.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | — | -900.3% | -869.6% |
| FY2017 | 100.0% | -556.2% | -545.9% |
| FY2018 | 97.6% | -1,087.6% | -1,016.6% |
| FY2019 | 88.6% | -427.5% | -403.2% |
| FY2020 | 84.9% | -168.1% | -174.1% |